Marwan Shaheen

发表

Current practice of oral care for hematopoietic stem cell transplant patients: A survey of the Eastern Mediterranean Blood and Marrow transplantation group.

Waleed A. Alamoudi, M. Aljurf, W. Jastaniah, 2021, Hematology/oncology and stem cell therapy.

Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population.

F. Alkuraya, S. AlKhater, T. Algoufi, 2019, American journal of human genetics.

Allogeneic transplant compared to pediatric-inspired therapy for Philadelphia chromosome-negative adolescent and adult ALL in first complete remission

M. Aljurf, A. Kotb, N. Chaudhri, 2022, Bone Marrow Transplantation.

Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms‐like tyrosine kinase 3‐mutated acute myeloid leukemia

A. Vekhoff, M. Mohty, M. Aljurf, 2017, Cancer.

COVID - 19 post Hematopoietic Cell Transplant, a Report of 11 Cases from a Single Center

M. Aljurf, R. El Fakih, S. Ahmed, 2020, Mediterranean journal of hematology and infectious diseases.

A case of T-cell lymphoproliferative disorder associated with hypereosinophilia with excellent response to mycophenolate mofetil.

R. El Fakih, S. Ahmed, Marwan Shaheen, 2017, Hematology/oncology and stem cell therapy.

The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities

M. Aljurf, N. Chaudhri, S. Hashmi, 2021, EJHaem.

Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome.

M. Aljurf, A. Kotb, N. Chaudhri, 2019, Clinical lymphoma, myeloma & leukemia.

Full dose Cyclophosphamide with the addition of Fludarabine for Matched Sibling transplants in Severe Aplastic Anemia: Flu/Cy conditioning for SAA.

M. Aljurf, A. Kotb, N. Chaudhri, 2021, Transplantation and cellular therapy.

Predictive value of molecular remissions postconsolidation chemotherapy in patients with Core Binding Factor Acute Myeloid Leukemia (CBF‐AML) – a single center analysis

M. Minden, S. Kamel‐Reid, A. Schimmer, 2017, Hematological oncology.

Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community

A. Eldali, N. Chaudhri, S. Hashmi, 2018, Bone Marrow Transplantation.

Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation.

M. Aljurf, M. Kharfan-Dabaja, Marwan Shaheen, 2015, Immunotherapy.

Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol – a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center

M. Aljurf, A. Kotb, N. Chaudhri, 2021, Leukemia research reports.

Unique aspects of Graft-versus-host-disease management in the Eastern Mediterranean region: Report from the Eastern Mediterranean blood and marrow transplantation group: Special report.

M. Aljurf, W. Jastaniah, M. Ayas, 2020, Hematology/oncology and stem cell therapy.

Haploidentical Stem Cell Transplantation: A Gateway to Infrequent Availability of HLA-Matched Related Donors

S. Hashmi, H. Aslam, Marwan Shaheen, 2018, Case reports in medicine.

Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes

M. Aljurf, A. Eldali, N. Chaudhri, 2018, Bone Marrow Transplantation.

Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts

M. Aljurf, A. Kotb, N. Chaudhri, 2021, Annals of Hematology.

Hemophagocytic lymphohistiocytosis: A rare cause of recurrent encephalopathy.

N. Kaya, Z. Al-Hassnan, M. Al-Owain, 2016, Intractable & rare diseases research.

Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population.

F. Alkuraya, S. AlKhater, T. Algoufi, 2019, American journal of human genetics.

Azacitidine Use for Myeloid Neoplasms

R. Komrokji, R. El Fakih, W. Rasheed, 2018, Clinical lymphoma, myeloma & leukemia.

Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT)

M. Aljurf, A. Ghavamzadeh, A. Bazarbachi, 2020, Bone Marrow Transplantation.

Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia

M. Aljurf, N. Chaudhri, S. Hashmi, 2021, Annals of Saudi medicine.

Outcomes of allogeneic hematopoietic cell transplant for acute myeloid leukemia in adolescent patients

M. Aljurf, A. Kotb, N. Chaudhri, 2019, Bone Marrow Transplantation.

“Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation”

M. Aljurf, N. Chaudhri, R. El Fakih, 2023, Bone Marrow Transplantation.

Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia

M. Aljurf, A. Kotb, N. Chaudhri, 2023, International journal of hematologic oncology.

Lung transplantation for pulmonary graft versus host disease: experience from a referral organ transplantation center

M. Aljurf, N. Chaudhri, W. Rasheed, 2023, Bone Marrow Transplantation.

Myeloablative Haploidentical donor hematopoietic transplantation using post-transplant cyclophosphamide and antithymoglobulin.

N. Chaudhri, W. Rasheed, S. Ahmed, 2024, Transplantation and cellular therapy.

Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell source.

M. Aljurf, N. Chaudhri, W. Rasheed, 2023, Cytotherapy.

Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients

N. Chaudhri, W. Rasheed, S. Ahmed, 2024, Annals of Saudi medicine.

Hematopoietic stem cell transplantation in Saudi Arabia between 1984 and 2016: Experience from four leading tertiary care hematopoietic stem cell transplantation centers.

M. Aljurf, A. Aljefri, M. Ayas, 2020, Hematology/oncology and stem cell therapy.